The National Academy of Medicine has formed a steering group featuring health system executives aiming to boost patient safety with AI.
The Patient Safety in the Era of AI effort launched March 3 and plans to develop national strategic options for leveraging AI to improve the safety of patients and prevent harm.
The initiative’s steering group is co-chaired by Gianrico Farrugia, M.D., president and CEO of Rochester, Minn.-based Mayo Clinic and Wright Lassiter, president and CEO of Chicago-based CommonSpirit Health and also includes Seattle Children’s CEO Christopher Longhurst, MD, and Peter Pronovost, MD, PhD, chief quality and clinical transformation officer of Cleveland-based University Hospitals.
“I am convinced that emerging AI tools may markedly increase patient safety improvements and do so at scale, but realizing that promise requires deliberate, cross-sector collaboration and thoughtful strategy,” Dr. Farrugia said in a March 4 news release.
Mr. Lassiter stated that patient safety is the “ideal use case for health AI.”
The initiative’s funders include the Elevance Health Foundation, Association for the Advancement of Medical Instrumentation, California Health Care Foundation and health tech company Premier Inc.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
